This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Skip to main content
United Kingdom | EN-GB

Add a bookmark to get started

Cortex - Life Sciences Insights

| less than a minute read

Understanding AI and its use in drug discovery

As part of our on-going podcast series - At the intersection of Science and Law, DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.

You can listen to the podcast here or for more information, please get in touch. 

Tags

artificial intelligence, podcast, healthtech